Tsuji Y, Ikuta H, Shibagaki F
Dept. of Surgery, Mitsu Municipal Hospital.
Gan To Kagaku Ryoho. 1995 Feb;22(2):273-6.
A 66-year-old female was admitted to our hospital with the complaint of anorexia and epigastric pain. Examination of the gastrointestinal tract revealed Borrmann III type gastric carcinoma, 5 cm x 5 cm in size, in the lesser curvature of the stomach. Multiple liver metastases were detected on abdominal computed tomography. In January 1993, she underwent subtotal gastrectomy as a palliative therapy. Pathological diagnosis of the resected specimen was poorly differentiated adenocarcinoma. Two weeks after operation, administration of UFT (300-450 mg/day, orally) and mitomycin C (12 mg/three months, intravenously) was started. This chemotherapy had to be discontinued within six months because of its severe side effects, such as leukopenia and acral erythema. However, a marked reduction in the size of the metastatic liver tumors was observed on abdominal computed tomogram, and the patient is now (15 months after operation) alive without local recurrence or re-growth of liver metastatic tumors.
一名66岁女性因厌食和上腹部疼痛入院。胃肠道检查发现胃小弯处有大小为5厘米×5厘米的Borrmann III型胃癌。腹部计算机断层扫描检测到多处肝转移。1993年1月,她接受了作为姑息治疗的胃次全切除术。切除标本的病理诊断为低分化腺癌。术后两周开始口服优福定(300 - 450毫克/天)和静脉注射丝裂霉素C(12毫克/三个月)。由于白细胞减少和手足红斑等严重副作用,这种化疗在六个月内不得不停止。然而,腹部计算机断层扫描显示转移性肝肿瘤大小明显缩小,患者目前(术后15个月)存活,无局部复发或肝转移肿瘤再生长。